Prediction of clinical outcomes after percutaneous coronary intervention: Machine-learning analysis of the National
Akhmetzhan Galimzhanov1, Andrija Matetic2, Erhan Tenekecioglu3
1Department of Propedeutics of Internal Disease, Semey Medical University, Semey, Kazakhstan; Keele Cardiovascular Research Group, Keele University, Keele, UK.
Insights
A machine-learning model accurately predicts mortality and adverse events in patients undergoing percutaneous coronary intervention (PCI). This tool uses routinely collected data for improved risk assessment and benchmarking.
Area of Science:
- Cardiovascular Medicine
- Medical Informatics
- Machine Learning in Healthcare
Background:
- Percutaneous coronary intervention (PCI) is a common procedure with associated risks.
- Predicting outcomes like mortality, ischemic events, and bleeding after PCI is crucial for patient management.
- Existing risk prediction models may not fully capture the complexity of these outcomes.
Purpose of the Study:
- To develop and validate a multiclass machine-learning (ML) model for predicting all-cause mortality, ischemic cerebrovascular events (CVE), and major bleeding in hospitalized patients undergoing PCI.
- To compare the performance of five common ML algorithms in this prediction task.
Main Methods:
- A retrospective analysis of 1,815,595 hospitalizations undergoing PCI from the National Inpatient Sample (2016-2019).
- Five ML algorithms (logistic regression, SVM, naive Bayes, RF, XGBoost) were trained and tested using 101 input features.
- Performance was evaluated using the area under the curve (AUC) with 95% confidence intervals (CI).
Main Results:
- The extreme gradient boosting (XGBoost) classifier achieved the highest performance with an AUC of 0.86 (95% CI 0.85-0.87), demonstrating excellent calibration.
- Other models like logistic regression, SVM, and RF also showed good predictive performance (AUCs ranging from 0.81 to 0.84).
- A web-based application was developed for real-time predictions using the XGBoost model.
Conclusions:
- A multi-task XGBoost classifier, utilizing 101 features, effectively predicts combinations of all-cause death, ischemic CVE, and major bleeding after PCI.
- These ML models can serve as valuable tools for benchmarking and risk stratification using readily available administrative data.
- The developed model and application offer potential for improved clinical decision-making and patient care.
Background:
This study aimed to develop a multiclass machine-learning (ML) model to predict all-cause mortality, ischemic and hemorrhagic events in unselected hospitalized patients undergoing percutaneous coronary intervention (PCI).
Methods:
This retrospective study included 1,815,595 unselected weighted hospitalizations undergoing PCI from the National Inpatient Sample (2016-2019). Five most common ML algorithms (logistic regression, support vector machine (SVM), naive Bayes, random forest (RF), and extreme gradient boosting (XGBoost)) were trained and tested with 101 input features. The study endpoints were different combinations of all-cause mortality, ischemic cerebrovascular events (CVE) and major bleeding. An area under the curve (AUC) with 95% confidence interval (95% CI) was selected as a performance metric.
Results:
The study population was split to a training cohort of 1,186,880 PCI discharges, validation cohort (for calibration) of 296,725 hospitalizations and a test cohort of 331,990 PCI discharges. A total of 98,180 (5.4%) hospital entries included study outcomes. Logistic regression, SVM, naive Bayes, and RF model demonstrated AUCs of 0.83 (95% CI 0.82-0.84), 0.84 (95% CI 0.83-0.86), 0.81 (95% CI 0.80-0.82), and 0.83 (95% CI 0.81-0.84), retrospectively. The XGBoost classifier performed the best with an AUC of 0.86 (95% CI 0.85-0.87) with excellent calibration. We then built a web-based application that provides predictions based on the XGBoost model.
Conclusion:
We derived the multi-task XGBoost classifier based on 101 features to predict different combinations of all-cause death, ischemic CVE and major bleeding. Such models may be useful in benchmarking and risk prediction using routinely collected administrative data.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
